Surgical Resection
Treatment for Gallbladder And Biliary Tract Cancer
Effectiveness
85%
Safety Score
35%
Clinical Trials
22
Participants
5M
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
35
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
1-3 months recovery, lifelong follow-up
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$10,000
Side Effect Mgmt:$15,000
Total Annual:$125,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
2
Outcome-Based Costs
Cost per Remission
$312,500
Comparison vs No surgery (for resectable disease)
Cost Difference
+$125,000/year
More expensive
QALY Difference
+2.00 QALYs
Better outcomes
Dominance
No dominance
Surgical Resection Outcomes
for Gallbladder And Biliary Tract Cancer
Efficacy Outcomes
Overall Effectiveness
+85%
Remission Rate
+40%
Common Side Effects
Pain
+90%
Infection
+15%
Bleeding
+7%
Anastomotic leak (if bile duct resection)
+10%
Pancreatitis (for Whipple)
+15%
Bile leak
+10%
Sources:
Active Clinical Trials
6 active trials recruiting for Surgical Resection in Gallbladder And Biliary Tract Cancer
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
NCT02920554RECRUITINGNA
88 participants
INTERVENTIONAL
Suwon, South Korea
Started: Jul 1, 2014
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
NCT06109779RECRUITINGPHASE3
750 participants
INTERVENTIONAL
Birmingham, United States +209 more
Started: Dec 4, 2023
Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.
NCT04735198RECRUITINGNA
100 participants
INTERVENTIONAL
Badalona, Spain +5 more
Started: Jan 20, 2021
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
NCT06901622ENROLLING BY INVITATIONPHASE2
50 participants
INTERVENTIONAL
Zhengzhou, China
Started: Nov 8, 2024
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
NCT02170090ACTIVE NOT RECRUITINGPHASE3
789 participants
INTERVENTIONAL
Bankstown, Australia +66 more
Started: Apr 1, 2014
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
NCT04559139ACTIVE NOT RECRUITINGPHASE2, PHASE3
186 participants
INTERVENTIONAL
Birmingham, United States +366 more
Started: Feb 24, 2021
Completed Clinical Trials
6 completed trials for Surgical Resection in Gallbladder And Biliary Tract Cancer
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
NCT00142480COMPLETEDPHASE2
8 participants
INTERVENTIONAL
Boston, United States +2 more
Started: Dec 1, 2004
Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy
NCT03510923COMPLETED
17.4K participants
OBSERVATIONAL
Amsterdam-Zuidoost, Netherlands
Started: May 1, 2018
Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
NCT06631352COMPLETED
50 participants
OBSERVATIONAL
Started: Jan 1, 2000
The Incidence of Gallstones After Gastric Cancer Surgery
NCT04250402COMPLETED
1.02K participants
OBSERVATIONAL
Lanzhou, China +1 more
Started: Feb 14, 2020
The Incidence of Gallstones After Gastrectomy
NCT05965466COMPLETEDNA
531 participants
INTERVENTIONAL
Lanzhou, China +1 more
Started: Jul 21, 2023
Needle Knife Fistulotomy Versus Partial Ampullary Endoscopic Mucosal Resection for Difficult Biliary Cannulation
NCT05068739COMPLETEDNA
80 participants
INTERVENTIONAL
Düzce, Turkey (Türkiye)
Started: Jun 1, 2021
Showing 20 of 22 total trials